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Abstract
Glycomics is the study of comprehensive structural elucidation and characterization of all glycoforms found in
nature and their dynamic spatiotemporal changes that are associated with biological processes. Glycocalyx of
mammalian cells actively participate in cell–cell, cell–matrix, and cell–pathogen interactions, which impact
embryogenesis, growth and development, homeostasis, infection and immunity, signaling, malignancy, and
metabolic disorders. Relative to genomics and proteomics, glycomics is just growing out of infancy with great
potential in biomedicine for biomarker discovery, diagnosis, and treatment. However, the immense diversity
and complexity of glycan structures and their multiple modes of interactions with proteins pose great challenges
for development of analytical tools for delineating structure function relationships and understanding glyco-
code. Several tools are being developed for glycan profiling based on chromatography, mass spectrometry,
glycan microarrays, and glyco-informatics. Lectins, which have long been used in glyco-immunology, printed on
a microarray provide a versatile platform for rapid high throughput analysis of glycoforms of biological sam-
ples. Herein, we summarize technological advances in lectin microarrays and critically review their impact on
glycomics analysis. Challenges remain in terms of expansion to include nonplant derived lectins, standardization
for routine clinical use, development of recombinant lectins, and exploration of plant kingdom for discovery of
novel lectins.
Introduction
Glycomics may be defined as the study of comprehen-sive elucidation and characterization of all the glyco-
forms (monosaccharides, oligosaccharides, polysaccharides,
and their modifications) found either independently or con-
jugated to other noncarbohydrate biomolecules (such as
proteins, lipids, and nucleic acids) and their dynamic spatio-
temporal changes that are associated with biological pro-
cesses (Hirabayashi et al., 2001). A glycoform refers to a single
homogeneous molecular species of a glycoconjugate carrying
a set of specific structure of glycans, which are oligosaccharide
chains—containing a glycoside bond between an anomeric
carbon of one monosaccharide and oxygen of another
monosaccharide—composed of various monosaccharide
units, connected in a specific linkage and stereochemical ori-
entation (Dell and Morris, 2001). As information carriers for
coding biological processes, carbohydrates far exceed bases of
nucleic acids and amino acids of proteins (Gabius, 2000). In
mammalian systems, glycoconjugates are found in the form of
glycoproteins, glycolipids, proteoglycans, and glycosylpho-
sphatidyl inositol (GPI) anchors. Additionally, glycosamino-
glycans (GAGs), which are composed of hexosamines and
hexuronic acids in an alternating manner, are found either as
free polysaccharides or as proteoglycans (Bishop et al., 2007;
Cummings, 2009; Sasisekharan et al., 2006; Turnbull et al.,
2001).
Mammalian glycan chains are made up of monosaccharide
building blocks, namely, hexoses (glucose, galactose, and
mannose), N-acetyl-hexosamines (glucosamine, mannosa-
mine, and galactosamine), deoxyhexoses (fucose), hexuronic
acids (glucuronic acid, iduronic acid), pentoses (xylose), and
nonuloses (sialic acids). The monosaccharides are found in the
dextro-(d) rotatory form, except fucose, which is found in the
levo-(l) rotatory form (Varki et al., 2008). All monosaccharide
building blocks found in mammalian glycoconjugates exhibit
hexopyranose ring structure. Although deoxyribonucleic ac-
ids (DNA) and ribonucleic acids (RNA) do contain deoxyri-
bose and ribose monosaccharide units in pentafuranose form
in their backbone, they are not considered as glycans as they
lack a glycosidic linkage.
Both prokaryotes and plants—owing to their diverse, ver-
satile, and easily adaptable biosynthetic machinery—exhibit
a large repertoire of monosaccharide building blocks (e.g.,
l-rhamnose, N-acetyl-d-fucosamine, etc.) as part of their
lipopolysaccharides (LPS), capsular polysaccharides (CPS),
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antibiotic glycosides, and plant-derived polysaccharides,
which in contrast, are not found in humans. Consequently, the
study of glycomics of prokaryotes and the plant kingdom is
indeed a daunting task in relation to mammalian genome
(Varki et al., 2008). The unique monosaccharide structures
and glycans found on bacteria are proving extremely valuable
determinants for identification, serotyping, and classification.
However, there are commonalities found with respect to
biosynthetic protein N-glycosylation pathways between plant
and mammalian systems, with the exception of sialic acids
which are unique to mammals (Wilson, 2002).
Advances in genomics have already reached a level of
commercial viability as evidenced by extensive use of
genome-wide and focussed DNA microarrays in research and
clinic. A logical follow-up was the study of proteomics, which
has reached a level of sophistication and automation sufficient
to be translated to the end user for biomarker discovery.
However, proteomics relies for a large part on differential
isotopic labeling, enzymatic digestion, resulting in a mixture
of peptides followed by mass spectrometry rather than anal-
ysis of whole proteins (Blackstock and Weir, 1999; Zaia, 2008).
Both genomics and proteomics are made ‘‘relatively’’ simple
thanks to their template-driven nature arising out of base-pair
complementarity and tri-nucleotide codon-driven transcrip-
tional and translational processes. The fruits of more than half
a century of research efforts in automated chemical synthesis
of peptides and nucleic acid primers, cloning, and expression
of proteins, gene silencing technology, epigenetics, and tran-
scriptome studies have greatly enabled the current level of
sophistication in genomics and proteomics. The past decade
has seen a growing realization of the importance of glycomics
perspective to immunology and biomedical challenges (Baum
and Crocker, 2009; Sharon and Lis, 1993).
In comparison to genomics and proteomics—where auto-
mated synthesis, amplification, expression, and character-
ization have become routine—the tools available for study of
glycomics are few. This necessitated the development of un-
ique tools that are currently reaching a reasonable level of
sophistication for use by nonspecialists (Bertozzi and Kies-
sling, 2001; Pilobello and Mahal, 2007; Prescher and Bertozzi,
2006). The enormous diversity of structures that can be cre-
ated using a limited number of monosaccharides building
blocks coupled with its non template-driven nature has made
the task of system-wide glycan profiling a challenging task
(Fig. 1) (Cummings, 2009; Gabius et al., 2004). A major ob-
stacle for the advancement of glycomics has been the lack of
sensitive and easy-to-use high-throughput analytical tools.
The availability of well-characterized enzymes with known
substrate specificities, such as PNGase-F (useful for cleaving
the intact N-linked glycans out of the asparagine (Asn) side
chain), endo-H (useful for cleaving the internal b-(1? 4)-
GlcNAc residue of N-linked glycans leaving one GlcNAc at-
tached to peptide backbone) and several plant and bacterial
glycosidases (useful for distinguishing specific anomeric
linkages), and analytical chromatographic methods, based on
electrochemical detection and fluorophore derivatization of
the reducing end anomeric carbon (Domann et al., 2007), en-
abled detailed and thorough characterization of the total oli-
gosaccharide structures and linkages (Ghesquiere et al., 2006;
Ramachandran et al., 2006). Parallel advances in stereo-
chemically controlled synthesis and purification of oligosac-
charides produced homogenous glycans that served as
reference standards for biological specimen-derived glycans,
haptens for conjugation, production of monoclonal anti-
bodies, and vaccine development (Buskas et al., 2006; See-
berger and Werz, 2007; Wang et al., 2007). However, the
characterization of a complete structure of a glycan using
enzymes and chromatography involves tedious and time-
consuming efforts (Ding et al., 2009; Patwa et al., 2009; Zhang,
2007).
The advent of proteomics and evolution of powerful yet
user-friendly mass spectrometry technologies, including
methodologies coupled to chromatography (known as hy-
phenated techniques) and bioinformatics, stimulated the rapid
analysis of glycans (Bielik and Zaia, 2010; von der Lieth et al.,
2006; Werz et al., 2007; Zaia, 2008). Mass spectrometry has the
advantage to rapidly scan and analyze samples in a high
throughput manner, once the glycans or glycopeptides have
been isolated, with or without permethylation, or enriched
using lectin-based affinity chromatography. However, unlike
peptides, which are made of amino acid as building blocks
with distinct molecular mass enabling easy identification of
unique peptide sequences, the isobaric nature of various
monosaccharide components of glycans complicates the as-
signment. So, although one could easily predict the size of the
oligosaccharides and general components such as number of
hexosamines, hexoses, sialic acids, etc., using mass spec-
trometry, the specific monosaccharides and their stereo-
chemical linkages have to be deduced based on known
biochemical pathways (North et al., 2009; von der Lieth et al.,
2006). High-end techniques such as tandem mass spectrom-
etry [MS]n, which study fragmentation of a given molecular
ion peak and generation of fingerprint-like patterns, are being
currently developed to identify the component monosaccha-
rides, their linkage positions, and anomeric orientations. The
inherently charged high-energy nature of molecular ions in
mass spectrometry leads to loss of posttranslational modifi-
cations (such as O-acetylation of sialic acids) and loss of sen-
sitive terminal sialic acid residues. To simplify the vast
number of structures possible for a given oligosaccharide
purely based on mathematical permutations and for matching
of a given mass spectrometry ion peak to relate to a minimal
set of glycans, qualified databases were developed using
known mammalian biosynthetic glycosylation pathways as
limiting parameters (Cooper et al., 2001; Goldberg et al., 2005;
McDonald et al., 2009). Rigorous mathematical models cor-
relating expression levels and activities of enzymes involved
in N-glycan biosynthetic pathways to the overall mass spec-
trometry profile of glycans have been developed to analyze
differential glycosylation patterns (Krambeck et al., 2009).
Notwithstanding intense efforts by multiple research groups,
the use of mass spectrometry as a stand-alone technique for
complete characterization of glycans is still far from complete.
To evaluate and validate the best possible combination of
techniques for glycome profiling as part of Human Proteome
Organization (HUPO) and Human Disease Glycomics/
Proteome Initiative (HGPI), a highly coordinated multi-insti-
tutional study of analysis of N-linked glycans was conducted
recently in 20 different labs using identical samples of human
IgG and transferrin. The study found that although there were
differences in sensitivities [limit of detection (LoD)] and the
derived glycoform profiles between various chromatographic
(trypsin or PNGase-F digestion, fluorophore derivatization,
electrochemical detection, and permethylation using LC or
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GC) and mass spectrometric techniques (MALDI or ESI of free
or permethylated glycans or glycopeptides); the outcome was
strikingly comparable considering the microheterogeneity of
glycans (Wada et al., 2007). Although MALDI-MS of per-
methylated glycans was found to be as good as chromato-
graphic techniques, it suffered from frequent loss of terminal
sialic acid residues. On the other hand, LC/ESI-MS was found
to retain sialic acids intact. The masses have to be mapped
with an online MALDI-MS glycomics database. In another
inter-laboratory study for structural analysis of N-linked
glycans, wide variations were found for levels of sialylation,
fucosylation, and antennary branching, highlighting method
variability and the need for well-characterized reference
standards (Thobhani et al., 2009).
Clearly, a comprehensive elucidation of intact glycoform
structures and their biological significance requires the in-
volvement of application of several complementary technol-
ogies. Although chromatography and mass spectrometry are
the mainstays for glycomics research, alternate technologies
suitable for rapid, high-throughput user-friendly analysis
at the ‘‘point-of-care’’ need to be developed. Toward this
end microarray-based technologies have come to the rescue.
Microarrays based on immobilized glycan ligands, either syn-
thetic, isolated from biological samples, or neoglycoconju-
gates have been developed and shown to be useful for the
detection and characterization of human lectins and bacteria
(Hsu and Mahal, 2009; Ito et al., 2009; Song et al., 2009). The
developments and achievements of carbohydrate–ligand-
based microarrays have been reviewed regularly and exten-
sively (Feizi and Chai, 2004; Hirabayashi, 2003; Horlacher and
Seeberger, 2006, 2008; Krishnamoorthy and Mahal, 2009;
Liang et al., 2008; Oyelaran and Gildersleeve, 2009; Paulson
et al., 2006). Microarrays wherein immobilized antibodies
(including anti-carbohydrate antibodies) were used to capture
a targeted set of glycoproteins and subsequent detection with
labeled lectins have been valuable in studying cancer-associ-
ated glycan alterations (Chen et al., 2007a). However, in the
case of anti-carbohydrate antibodies in particular, the reported
supplier-dependent variations and crossreactivity must be
taken in to account (Manimala et al., 2007). A complementary
approach is the design and development of microarray tech-
niques using immobilized lectins, which is the topic of this
review. The analysis of glycans seems to have taken a full circle
with the advent of lectin-based microarrays (Sharon, 1998).
Lectin and Carbohydrate Recognition
Early analysis of glycoforms relied heavily on screening of
biological samples using a wide variety of plant lectins. Lec-
tins, derived from Latin legere to pick out or choose, are de-
fined as proteins—that bind carbohydrates present on
glycoconjugates as ligands—that are neither enzymes (car-
bohydrate processing), antibodies (anticarbohydrate anti-
bodies), nor proteins that bind small carbohydrate molecules
(energy metabolism) (Goldstein et al., 1980). Lectins, which
are available in plenty in plant seeds and could be isolated in
enriched forms relatively easily, induced agglutination in
blood cells and were instrumental in the study of blood group
classification and as affinity matrices for purification of gly-
coproteins and cell separations (Rudiger and Gabius, 2001). It
was known as early as in the 1950s that the ligands to which
lectins bind on the mammalian cell surface were composed of
carbohydrate, as shown by competitive inhibition using spe-
cific monosaccharides (Morgan, 1970; Morgan and Watkins,
2000; Watkins and Morgan, 1957). Two classic examples are
the characterization of blood group antigens and the dem-
onstration of leukocyte homing based on glycan-derived re-
ceptors (Gesner and Ginsburg, 1964; Rosen, 2004). Pioneering
work on lectins and their carbohydrate binding specificities
by Sharon, Goldstein, Kornfeld, Brewer, Surolia, and several
FIG. 1. Complexity and diversity of mammalian glycome. The glycome represents the largest class of posttranslationally
modified molecules. The information flow from genome to glycome increases exponentially (diagram not drawn to scale).
Glycans amplify the genomic information content of cells providing functional diversity originating from only a single gene.
Genome, transcriptome, and proteome are governed by template-driven processes using unidirectional (nucleotide base pairs
indicated using single letter codes) or bidirectional building blocks (amino acids indicated by standard single-letter codes). In
contrast, glycome is generated by complex biosynthetic glycosylation pathways in a non template-driven manner, governed
by availability of carbohydrate substrates, expression and activity levels of enzymes and sugar–nucleotide transporters. The
monosaccharide building blocks (shown using standard abbreviations) of mammalian glycans are combined in a multidi-
rectional manner and exhibit linkage and stereo isomerism and frequent branching.
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others have set a strong biochemical foundation (Brewer et al.,
2002; Dam and Brewer, 2002, 2010; Lis and Sharon, 1986;
Sacchettini et al., 2001; Sharon, 2007, 2008; Sharon and Lis,
2004). In mammalian physiology, endogenous lectins (e.g.,
galectins, siglecs, calreticulin, calnexin, etc.) regulate key
processes such as pattern recognition of pathogens, cell–cell
communications, correct folding of glycoproteins and quality
control (Caramelo and Parodi, 2007; Gabius et al., 2002;
Shanmugham et al., 2006). Lectins are known to play vital
roles in plant physiology, development, and stress response.
As part of the innate immune system, sometimes coupled
with ribosome inactivating proteins, for example, ricin, lectins
ward off attacks by pathogens, parasites, and predators (De
Hoff et al., 2009). On the other hand, lectins act as tools for
screening and agglutination, via interaction with bacterial
polysaccharides including Nod factors, for attachment of
symbiotic bacteria (e.g., rhizobia) and fungi, which help in
nitrogen fixation and facilitate mutualism.
Origin of Studies on Microheterogeneity,
Structure of Glycans, and Lectins
The classic works of Sharon and coworkers (Lis and Shar-
on, 1986; Sharon, 2008; Sharon and Lis, 2004), Goldstein and
coworkers (Goldstein, 2009; Shibuya et al., 1988), Cummings
and Kornfeld (1982), Debray and coworkers (1981), Baenziger
and Fiete (1979a, 1979b, 1982), and Surolia and coworkers
(Mitra et al., 2003; Surolia et al., 1974, 1980) with lectins set the
pace for defining glycan structures and heterogeneities in-
volved therein. Sharon (2007) has pioneered the structure and
carbohydrate specificities of lectins particularly soy bean ag-
glutinin (SBA) and Erythrina corallodendron lectin (ECorL)
and the importance of their glycosylation. Goldstein and co-
workers have studied the interactions of Conconavalin A
(Con A) with several simple and complex carbohydrates. In
their classic article they demonstrate that Con A precipitates
with purified monoclonal IgM and also binds the various
carbohydrate moieties present on the surface of lectins from
waxbean and soybean, which contain terminal nonreducing
a-d-mannopyranosyl, a-d-glucopyranosyl, and b-d-fructo-
furanosyl residues (Shibuya et al., 1988). Cummings and
Kornfeld (1982) demonstrated that serial lectin–agarose
chromatography (SLAC) is a rapid, sensitive, and specific
technique that can be used for fractionating and analyzing N-
linked oligosaccharides. The fractionation scheme involved
serial chromatography on Con A– Sepharose, pea lectin–
Sepharose, and leukoagglutinating phytohemagglutinin–
Sepharose. The various fractions eluted from the columns
contained relatively pure populations of glycopeptides that
could be further used for structural analysis. Debray and co-
workers (1981) elucidated the interactions of various oligo-
saccharides with 12 different lectins in an exhaustive manner
to obtain carbohydrate specificities. Surolia and coworkers
(1980) have demonstrated the power of lectin binding meth-
odology for identifying the various glycoforms and micro-
heterogeneity in glycoproteins before glycan mass
spectrometry was in vogue. The use of monovalent lectin-
affinity purification was demonstrated by deliberately gen-
erating microheterogeneity by subjecting fetuin to partial
hydrolysis. Partial hydrolysis of fetuin resulted in various
asialoglycoforms that stoichiometrically bound monovalent
radioactive-labeled ricin, in a manner proportional to the
number of asialo-glycan units per protein chain. The various
ricin–fetuin complexes could be easily separated by gel fil-
tration. However, the technique itself being cumbersome and
time consuming, the studies in this direction were not pur-
sued further. Studies by Baenziger and Fiete (1982) described
in detail the binding affinities of a number of N- and O-linked
oligosaccharides with several lectins, as well as the usage of
photoactivable glycopeptides reagents for site-specific label-
ing of lectins. They synthesized photoactivable iodinated
glycopeptides bearing oligosaccharides of defined structure.
Con A, Ricinus communis agglutinin and toxin, RCAI and
RCAII, respectively, and Gal/GalNAc-specific lectin from
human and rat hepatocytes were used for the study. They
demonstrated that covalent incorporation upon photoactiva-
tion only occurs with a glycopeptide that is specifically bound
by the lectin and inhibited only by appropriate monosaccha-
rides. This high degree of affinity and specificity of photo-
activable glycopeptides identified them as promising agents
for examination of lectins. Extensive studies by Brewer and
coworkers, Surolia and coworkers, and others using iso-
thermal calorimetry have provided enormous data on the
thermodynamics of lectin–carbohydrate interactions and
multivalency (Dam and Brewer, 2002; Mitra et al., 2003). In an
elegant study highlighting importance of both carbohydrate
ligand density as well as relative spatial orientation and
dynamics of carbohydrate–lectin interactions, Srinivas and
coworkers (2002, 2005) synthesized photo-switchable glyco-
ligands with an azobenzene core moiety which undergoes
cis–trans isomerism upon irradiation. The existence of co-
operativity in lectin–ligand binding was shown using bi-
phasic binding curve of PNA with azobenzene-bis-lactose
derivative, by isothermal calorimetry (ITC). Vast amount of
knowledge gathered over four decades on structure of lectins,
carbohydrate ligands, and their binding selectivities, and
thermodynamic parameters using solution-based methodol-
ogies, and studies on multivalency or clustering effect for in-
creased avidity of lectin–carbohydrate interactions (Lee and
Lee, 1995, 2000; Lundquist and Toone, 2002) have together
helped take lectins to the next level in the form of lectin array
to address the challenge of glycan profiling.
Lectin Microarrays—Evolution of a Platform
Technology
In tune and keeping pace with the dawn of 21st century and
development of high-throughput technologies in genomics
and proteomics, it was logical for glycomics analysis to
quickly follow suit. The time was opportune to put the large
amount of knowledge accumulated in lectin biochemistry
over four decades to fruitful applications. Toward this end,
lectin microarrays were developed wherein several lectins
were immobilized to a suitable solid phase (microscopic slide)
optimized using multiple chemical methodologies, conditions
(humidity, buffer, and temperature), spot size and spot mor-
phology. Table 1 illustrates the number of studies performed
to date along with total number of lectins per array, method of
detection, and the nature of analyte (ranging from mono- and
oligo-saccharides, neo-glycoconjugates, purified glycans,
glycoproteins, crude lysates, membrane preparation, whole-
cell bacteria, and intact mammalian cells). Methods for lectin
immobilization rely on various methods such as (1) carbene
insertion, (2) biotin–avidin bridge, (3) attachment of amine
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functional group of lysine side chains of protein-backbone
of lectins for immobilization to solid surface through
epoxy-functionalized (glycidyl derivative) or N-hydro-
xysuccinimidyl (NHS)-derived esters, (4) exploitation of self-
assembled monolayers of thiols on gold-coated surfaces, and
(5) 3D hydrogel surfaces (Fig. 2). In all methods there is a lack
of absolute control in guaranteeing the optimal orientation,
native multimeric quarternary structure, optimal multivalent
clustering of carbohydrate recognition domains (CRD) of
lectins and their metal ion requirements, such as Caþ2, Mgþ2,
etc. Curiously, the carbohydrate portion of lectins (except
WGA, Con A, PNA, which are not glycosylated) has not been
exploited as an anchor point. A mild periodate-based oxida-
tion of glycan chains of lectin, as employed for glycosylated
antibody microarrays (Chen et al., 2007a), followed by an-
choring to hydroxylamine or hydrazine containing solid
surfaces should be a useful approach. This method would
leave the CRD of lectins intact, tuck away the crossreacting
glycan portions of lectin, and might greatly improve optimal
orientation of lectins in their native multimeric forms. Such
hydrazide or hydroxylamine based methodologies have been
used to capture glycans from glycoproteins and mammalian
cells (Wollscheid et al., 2009).
Detection and differentiation of glycoforms on proteins
In a first proof-of-concept demonstration of feasibility of
lectin arrays for distinct detection of terminal carbohydrate
moieties on glycoproteins Angeloni and coworkers (2005)
designed a miniarray. Employing a set of four lectins, namely,
peanut agglutinin (PNA), Sambucus nigra lectin (SNA), Dan-
tura stramonia lectin (DSA), and Ulex europaeus lectin (UEA), it
was shown that the differences in terminal sugar epitopes
could be detected with good sensitivity. Biotinylated lectins
were immobilized on Opto-Dex–biotin plates using neu-
travidin as a bridge. A selected set of purified glycoproteins
labeled either with Cy3 or Cy5 were used as analytes. The
fluorescent labeling of glycoproteins was performed with an
excess of the dye and purified by size exclusion chroma-
tography. For quantitative studies, it will be important to
know the exact stoichiometry of number of fluorophores co-
valently linked for each molecule of glycoprotein, as the
fluorescence emission and quantum efficiency may be a
function of number of fluorophores per molecule. A number
of fluorophores in close proximity may lead either to mutual
enhancement of emission signal intensity or internal
quenching depending on the microenvironment of the gly-
coprotein under consideration (Yamaguchi et al., 2008). It is
not clear if these glycoproteins [excluding neoglycoconjugates
of bovine serum albumin (BSA) and dextrose] consisted of
multiple glycoforms. If so, it was at least not detected in this
array with limited number of lectins or there was selective
capturing of some glycoforms, whereas others were lost due
to washing. Notably, in an alternative methodology, when
photochemical activation of diazirine moieties on modified
dextran was employed for covalent crosslinking of lectins, the
carbohydrate binding activity of lectins was found to be lost.
In addition to structural rearrangement of CRD upon carbene
insertion reaction, the carbohydrate binding by lectin may
have been compromised by the multiple points of attachment
of a lectin on dextran. The aspect regarding the correct, if not,
at least flexible or adaptable orientation of the carbohydrate-
binding moiety on the surface of immobilization cannot be
overemphasized for routine use of lectin microarray tech-
nologies. In comparison to cDNA microarray employed for
genomics where true sequence-dependent and strong binding
or ‘‘hybridization’’ occurs owing to complementary base pairs
and hydrogen bonds, the interactions between glycan epi-
topes and lectins depend heavily on weak, albeit selective,
complementarity of three-dimensional binding spaces
through hydrogen bonds and van der Waals forces.
In another effort for rapid analysis of glycopatterns of
proteins, Pilobello and coworkers reported a lectin array
consisting of nine commonly available lectins. The lectins
were covalently immobilized directly on to aldehyde or epoxide-
derivatized glass slides. The array was probed using Cy3-
conjugated chicken ovalbumin and found to exhibit selective
binding consistent with earlier reports of N-linked glycans
present on ovalbumin. The sample of ovalbumin contained
many accessible terminal GlcNAc glycans predominantly
as shown by their exclusive binding to Con A, Griffonia
simplifolica lectin (GSL-II) and wheat germ agglutinin (WGA)
(Pilobello et al., 2005). Although the lectins were selected
to cover a wide range of substrate specificities, the above-
mentioned three lectins possess overlapping selectivity for
GlcNAc. The epoxy-derivatized slides seem to be somewhat
better than aldehyde derivatized slides in terms of spot
morphology and homogeneity; both the array substrates
provided qualitatively similar results. To establish selective
binding with terminal GlcNAc competitive inhibition studies
were conducted using free GlcNAc and Gal. In all the three
lectins, Con A, GSL-II, and WGA, the binding, and hence
fluorescence, was abolished by GlcNAc but not Gal, which
was as expected. It is not clear if other monosaccharides were
studied for competitive inhibition. For example, use of man-
nose (Man) as a competing monosaccharide control, in ad-
dition to Gal, might have shown a higher differential affinity
for Con A binding of Cy3-ovalbumin. Additional studies us-
ing Cy-3 labeled porcine gastric mucin and bovine salivary
mucin exhibited qualitative differences in lectin binding in-
dicating the feasibility of microarrays. The sensitivity of de-
tection and pattern was found to be conserved when the spot
size was reduced to *80 microns using automated arrayer
from *750 microns with manual arrayer. However, the lack
of efficient binding of mucins to SNA was attributed to con-
flicting reports of selective substrates for SNA and supplier
dependent variations. It is not clear if the sample of Cy-3-
conjugated ovalbumin (analyte) used, which could exhibit
batch-to-batch variations in microheterogeneity of glyco-
forms, was independently tested for presence of sialic acid
containing N-glycans using routine periodate-resorcinol,
thiobarbituric acid or other assays. It is possible the Cy-3 (a
fluorophore with a positive charge) derivatization of oval-
bumin sterically and electrostatically prohibited the interac-
tion of sialoglycans with SNA. Importantly, the stoichiometry
of number of fluorophore molecules per molecule of albumin
may be crucial in achieving consistent results. Chicken oval-
bumin has 20 lysine residues, although not all are equally
accessible to Cy-3-NHS ester, and an N-terminal amino
group. The average pattern of Cy-3 derivatization could alter
the selective binding characteristics to lectins. The aspect of
weak and overlapping binding affinities among the lectins
selected restricted use of other glycoproteins with heteroge-
neous glycoforms. Also, the efficiency of interaction of solid
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surface anchored lectins with soluble fluorescence-labeled li-
gands may have been compromised due to lack of control
over optimal orientations of carbohydrate binding regions for
productive binding, which would directly affect sensitivity
and LoD. In addition to monosaccharide competition assays,
a key negative control using completely de-glycosylated Cy-
3-conjugated ovalbumin would have been more useful in
authenticating specificity of lectin binding and eliminating
possible binding contributions from protein–protein affinities
and fluorophore–protein interactions (Podder et al., 1974).
Analysis of intact mammalian cells
In a first example of proof-of-principle application of lectin
arrays for the distinction of cell types based on accessible
glyco-epitopes on cell surface, Zheng and coworkers (Chen
et al., 2007b; Zheng et al. 2005, 2007) exploited self-assembled
monolayers of N-hydroxysuccinimidyl (NHS)-activated long
chain hydrocarbon thiols on gold surfaces. A set of commonly
available lectins were hand spotted using 500 nL of lectin
solutions. Binding studies using fluorescein-tagged (a fluor-
ophore with a negative charge) chicken ovalbumin gave re-
sults as anticipated by binding to Con A, GSL-II, SNA, WGA,
and RCA120, but not to UEA. Unlike the earlier study using
Cy-3-ovalbumin, which did not show any binding to SNA, the
fluorescein isothiocyanate (FITC)-labeled ovalbumin here did
exhibit binding to SNA. Such discrepancies could arise due to
multiple factors including (1) spot size and morphology, (2)
orientation of lectin binding site, (3) batch-to-batch variation
of ovalbumin glycoforms, and (4) chemical nature, charge,
and loading density of the fluorophore on the glycoprotein.
These factors highlight the importance of developing uniform
standardization and validation protocols before lectin mi-
croarrays could become a routine diagnostic device at the
clinics.
A comparison of binding affinities of BHK-21 (Syrian
hamster kidney fibroblasts) and Caco-2 (human colorectal
adenocarcinoma) cell lines revealed differential binding pat-
terns on a six-lectin array (Zheng et al., 2005, 2007). BHK-21
cells bound to three out of six lectins—Con A, WGA, and
RCA—indicating accessible epitopes of mannose, GlcNAc,
and Gal, respectively. On the other hand, Caco-2 cells bound
to two additional lectins—SNA and UEA—indicating addi-
tionally accessible sialic acid and fucosyl moieties. Both BHK-
21 and Caco-2 did not bind to GSL-II, indicating absence of
accessible terminal GlcNAc epitopes. No additional proof of
absence or presence of sialic acid and fucosyl moieties on
BHK-21 and relative sialic acid content between the two cell
lines was provided. It is interesting to note that the compari-
sons were made between a hamster and a human cell line,
resulting in sharp contrast highlighting the species dependent
variations. Also, that lack of binding of BHK-21 cells to SNA
might be due to the abundance of N-glycolyl-neuraminic acid
epitopes, instead of N-acetyl-neuraminic acid moieties, which
FIG. 2. Summary of lectin microarray technologies. Lectin microarrays have been fabricated using various immobilization
technologies (1) using lectins derived from multiple sources (2). The binding of glycoconjugates from a diverse set of analytes
of biological samples (3) have been detected using multiple detection approaches (4). Lectin microarrays provide a rapid,
sensitive, and high-throughput screening tools for glyco-profiling resulting in important biomedical applications (5). Si-
multaneous application of lectin microarrays with complementary glycomics technologies holds potential for decoding the
‘‘glycocode’’ and development of new and effective diagnostics and therapeutics. SAM, self-assembled monolayers; SELDI,
surface enhanced laser desorption ionization; NHS, N-hydroxysuccinimide esters; Au, gold-coated surfaces.
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may not be bound as tightly by SNA (Knibbs et al., 1991;
Taatjes et al., 1988).
Detection of pathogens
In an elegant application for the detection, differential
characterization of both pathogenic and nonpathogenic bac-
teria (applicable for Gram-negative strains that express dis-
tinct carbohydrate derived O-antigens attached to LPS on
their surface) and monitoring of dynamic changes during
bacterial growth, Hsu and coworkers (2006) have designed
microarrays with 21-lectins. Importantly, it was noted that use
of minimum amount of glycerol and a 1.0-mM solution of
respective ligand for each lectin significantly improved the
spot morphology and accessibility of CRD of lectin (Hsu and
Mahal, 2006). Differential lectin binding patterns could be
obtained for SYTO 85 fluorescent dye-labeled nonpathogenic
Escherichia coli K12 strains JM101 and HB101, pathogenic
E. coli RS218, and Salmonella typhimurium LT2, with RS218
binding to maximum number of lectins. The lectin binding
could be selectively abrogated by coincubation with com-
petitive ligands such as lactose, and the intensity of fluores-
cence was shown to decrease as the bacteria changed from
logarithmic growth phase to stationary phase. Binding to si-
alic acid and fucose specific lectins [Maackia amurensis agglu-
tinin (MAA), SNA, and UEA-I] was observed for RS218,
which is known to aid in evasion of host cell immune re-
sponse. It would be interesting to apply this lectin microarray
approach to other bacteria such as M. tuberculosis and para-
sitic pathogens that cause tropical disease such as malaria and
leishmaniasis. The studies on dynamic changes to their ac-
cessible cell surface glycoforms could provide valuable in-
sight in the mechanisms of immune evasion and switching
between active and dormant phase, particularly in the context
of latency of tuberculosis (Hirsch et al., 1997).
Analysis of glycosylation status of biopharmaceuticals
Soluble antibodies and proteins in body fluids play vital
roles in regulating homeostasis, development, and pathogen
detection through immune surveillance. The changes in gly-
coform expressed by antibodies are known to have differen-
tial downstream effects. On the other hand, the recent clinical
success of biopharmaceuticals consisting of glycoproteins,
such as therapeutic monoclonal antibodies and erythropoietin
(EPO), has raised many challenges for definition of homoge-
neity, quality control, and batch-to-batch consistency (Sinclair
and Elliott, 2005). Lectin microarrays provide a convenient,
simple, and rapid means of comparing patterns generated by
various glycoforms of a given protein produced under dif-
ferent expression systems, fermentation, and mammalian
bioreactor conditions. For this purpose, Rosenfeld and co-
workers (2007) successfully applied a commercially available
glycoarrays kit called QproteomeTM consisting of 24 plant-
derived lectins for the analysis of various glycoproteins in-
cluding RNase B, prostate-specific antigen (PSA), porcine
thyroglobulin, Tamm Horsfall glycoprotein, and recombinant
human EPO. The analysis involved simplified algorithms that
categorize binding according to the type of glycan present on
the analyte and a relative grading system. Such ready-to-use
kits are valuable to nonspecialists as a rapid quality control
assay, and to specialists for preliminary screening of biologi-
cal samples.
Detection in solution—evanescent field fluorescence
To generate unique patterns and to overcome promiscuity
of lectin/carbohydrate interactions it was imperative that
repertoire of lectins be increased on the microarray. Unlike
antigen–antibody interactions that exhibit dissociation constant
(Kd) in the nano- to femto molar range, lectin–carbohydrate
or lectin–glycan interactions exhibit only moderate binding
affinities, with Kd in micromolar range. Considering the
number of washing steps involved in microarray methodol-
ogies and weak-to-moderate binding affinities, it is possible
that majority of lectin interactions could be lost. To overcome
this drawback and to be able to study glycan binding to lectin
array in solution, Kuno and coworkers (2005) elegantly ap-
plied the evanescent field fluorescence-based detection. This
methodology, also known as total internal reflection fluores-
cence (TIRF) microscopy, has been used to study interactions
of basal membrane of cells with substrates (extracellular ma-
trix and biomaterials) (Fish, 2009). The application of eva-
nescent field fluorescence-based detection eliminated the
need for washings of substrate solutions as only a very thin
surface (<100 nm) from the solid surface is scanned, and thus,
only true equilibrium events are detected. Also, real-time
monitoring of binding events could be measured enabling the
determination of optimal time of incubation for various lec-
tins. Using a microarray containing 39 lectins, it was shown
that status of glycosylation and glycoforms of proteins such as
RNase A (nonglycosylated control), RNase B, asialofetuin,
fetuin, and bovine serum albumins could be analyzed. Dis-
tinct patterns were obtained for glycoproteins such as asia-
lofetuin, mouse laminin, bovine transferrin, and horse radish
peroxidise (HRP) (a plant glycoprotein) reflecting variations
in their glycoforms in both N-linked and O-linked glycan
structures. The potential of microarray for fine glycan struc-
ture determination was shown by enzymatic cleavage of
tetramethylrhodamine (TMR)- labeled Asn-containing oligo-
saccharide using a panel of enzymes specific for glycan
linkages. The evanescent field fluorescence detection is very
powerful, convenient, and capable of high throughput
(Hirabayashi, 2008). However, for studies of mixture of gly-
coproteins from biological samples, multiple real-time images
should be acquired and kinetics of equilibrium followed to
find optimal time points necessary to achieve differential
patterns (Ebe et al., 2006).
Further improvement in sensitivity and limit of detection
has been achieved by systematic optimization of critical pa-
rameters such as lectin spotting, chemistry of immobilization,
nature of the solid surface, temperature, humidity, blocking
agent, and buffer conditions. Thus, Uchiyama and coworkers
were able to detect even monovalent oligosaccharides that
exhibit low affinity towards lectins (Uchiyama et al., 2008).
The binding of asialofetuin and an N-glycan oligosaccharide
probe carrying asialo-biantennary glycans to RCA120 could
be detected at concentrations as low as 100 pg/mL and
100 pM, respectively. Also, with optimized spotting condi-
tions the reproducibility was improved. Closely related gly-
can structures for which no specific lectins exist, such as Lewis
A [Gal-b-(1? 3)-(Fuc-a-(1? 4)-GlcNAc] and Lewis X [Gal-b-
(1? 4)-(Fuc-a-(1? 3))-GlcNAc] that are positional isomers,
could be distinguished clearly based on the overall binding
pattern on the 43-lectin microarray. The lectins UEA-I and
Bauhinia purpuria alba lectin (BPL) showed opposite affinities
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for the isomers and a ratio of intensities of BPL/UEA-1 was
taken to quantify binding. These results were in agreement
with quantitative sugar-protein interaction affinity values
measured using frontal affinity chromatography (FAC) (Hir-
abayashi, 2004; Tateno et al., 2007a).
Expanding the repertoire of lectin arrays
The ability of lectins to selectively recognize and bind
carbohydrate ligands of glycoconjugates and its potential
application to glycomic profiling in the form of lectin mi-
croarray was soon realized. Many carbohydrate ligands are
bound by several lectins with varying affinities. Conversely,
several lectins are available that bind to the same carbohy-
drate epitope. This results in overlapping affinities and rec-
ognition for both lectins and ligands. Therefore, to achieve
unique and specific patterns for a given glycoconjugate or
cell surface glycome microarrays a larger set of lectins should
be more useful. Toward this end, Tateno and coworkers
(2007b) developed a microarray containing 43 lectins, and
showed that it can be used to obtain unique and distinct
signature patterns for Chinese hamster ovary (CHO) cells
and its specific mutants Lec2 (deficient in CMP-sialic acid
transporter), Lec8 (deficient in UDP-Gal transporter), and
Lec1 [deficient in b-(1? 2)-N-acetylglucosaminyltransferase
I (GnT-1)], which are known to exhibit major changes in their
cell surface glycoforms. The lectin binding data compared
mostly well with the literature data obtained by flow cy-
tometry and other techniques and based on predicted defects
in glycosylation. However, anomalous binding of cells to
unexpected lectins were found in some cases, such as Tri-
chosanthes japonica lectin (TJA-I) [a-(2? 6)-NeuAc binder] for
Lec2 (defective in sialylation), SNA [a-(2? 6)-NeuAc bind-
er] for Lec8 (defective in both sialylation and galactosyla-
tion), and little differential binding to Con A (mannose
binder) for Lec1 (defective in GlcNAc-ylation). These dis-
crepancies were explained by promiscuous binding to other
less preferred ligands and to the availability of unique
multivalent formations available on intact mammalian cell
surface. This highlights an inherent disadvantage of lectin
array, that several lectins bind a given carbohydrate epitope
and that several carbohydrate epitopes bind a given lectin
albeit with varying quantitative affinities, which precludes
creation of a mutually exclusive orthogonal set of lectin and
ligands. The 43-lectin array has been shown to generate
differential patterns for murine splenocytes from WT and
b-(1? 3)-N-acetylglucosaminyl transferase II (b3GnT2) (de-
fective in biosynthesis of poly-N-acetyl lactosamine) knock-
out mice consistent with the predicted changes in
glycosylation. As an evidence to the long-believed hypoth-
esis that cell surface glycoforms are characteristically dif-
ferent before and after differentiation, K562 (human
erythroleukemia) cells were differentiated using sodium
butyrate and studied by the 43-lectin array. As expected,
major changes were found in lectins that recognize mucin-
type oligosaccharides such as core 1, Tn (GalNAc) and sialo
mucin, which were consistent with reported literature. Ear-
lier biochemical studies have shown enhanced O-glycosyl-
ation of K562 cells upon differentiation (Gahmberg et al.,
1984) as well as enhanced O-GalNAc expression on CD43
(leukosialin) upon activation (Maemura and Fukuda, 1992;
Piller et al., 1989). Additionally, the 43-lectin array provided
distinct and unique binding patterns for a panel of 10 cell
lines, including Jurkat, HEK293, and THP-1.
In an attempt to increase the repertoire of lectins on mi-
croarray Tao et al. (2008) have reported a 94-lectin microarray
for generation of signature patterns for 24 mammalian cell
lines including breast cancer cells, identification of changes in
glycoforms between naive and activated B cells and T cells
and thymocytes, demonstration of carbohydrate-dependent
differential bacterial tropism among related cell types, and
identification of potential biomarkers for cancer stem-like
cells. Herein, a simplistic binary scoring approach (as in
bound or nonbound) was used to generate the patterns. Based
on the results of cell binding, lectins were classified in to four
categories namely, nonbinders, low, medium, and high
binders. Of the 94 lectins, 17 lectins did not bind any of 24 cell
types under study, which was attributed to low affinity and
low quality (crude preparations of lectins), and two lectins
were of unknown saccharide specificities. The binding of in-
tact cells to remaining 75 lectins displayed distinct patterns.
Some cell lines such as hESC, Caco-2, D407, and U937 were
found to bind only to 20 lectins on the array, whereas cell lines
such as Tag, 293, K1106, and MCF7 bound to more than 50
lectins. Also, the clustering of similar cell types was unpre-
dictable indicating that accessible glycoforms could be widely
different even among related cell types. Although the retina-
derived cell-lines clustered tightly, the related breast cancer
cell lines exhibited wide pattern variations. The binding pat-
tern found on the microarray was validated by flow cytom-
etry using selected lectins. Significant changes were found in
glycoforms of lymphocytes before and after activation in both
T and B cells. The array could distinguish the glycoforms in T
cells that were activated by two different agents [phorbol
myristyl acetate (PMA)/ionomycin and mixed lymphocyte
reaction (MLR)].
Pathogenic bacteria such as E. coli K12 exhibit cellular tro-
pism, that is, differential affinity to related cell types, and
invade selected cell populations in a host through its fimbriae
protein, which is a mannose binding lectin. Lectin array sig-
nature patterns of three related breast cancer cell lines indi-
cated that SkBr3 has higher cell surface mannose content
compared to MCF7 and MDA-MB-231, and hence, could be
used to predict bacterial tropism and pathogen-host cell in-
teractions. Experiments using WT E. coli K12 and FimH mu-
tant on the three cell lines confirmed the higher affinity of
E. coli to SkBr3 cell line, relative to MCF7 and MDA-MB-231.
To find unique biomarkers for identification and charac-
terization of cancer stem cell-like cells, differential lectin sig-
nature pattern was studied using MCF7 cells cultured either
as a monolayer (normal culturing) or as spehroidal bodies
(similar to embryonic stem cell culturing). Depending on the
nature of culturing, the lectin patterns were different, partic-
ularly for GlcNAc binding lectins such as Lycopersicon escu-
lentum lectin (LEL), Aleuria aurantia lectin (AAL), and WGA.
Based on this data, the MCF7 cells were depleted to remove
LEL-binding breast cancer cells to obtain a side population
enriched in cancer stem-like cells. These cells when injected in
mouse were found to result in higher tumor volume com-
pared to the nonenriched whole cell populations (Tao et al.,
2008). Thus, the changes in glycoforms, gleaned from lectin
microarray analysis, could result in biomarkers that can either
identify side populations or can be used to separate major
populations.
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Lectin coupled to mass spectrometry
Recently, using a set of two selected lectins, namely, Jacalin
and SNA, Ueda and coworkers (2009) have shown the ap-
plication of ProteinChip arrays and SELDI-TOF for discovery
of glycosylation disorders and disease specific alterations in
glycan structure in sera of lung cancer patients using a tar-
geted serum glycoproteomics approach. The two lectins were
covalently immobilized on the commercially available Pro-
teinChip array that carry carbonyldiimidazole moieties via
free amine groups present on lectins. The serum samples, after
depletion of 14 most abundant proteins, were captured on
lectins through their glycoforms and studies by mass spec-
trometry. Clear-cut and significant differences were found
between serum samples of healthy volunteers and lung cancer
patients, captured by Jacalin and SNA. Through extensive
MS/MS analysis for protein identification, glycosylation site
mapping, and glycan structure analysis, apolipoprotein C-III
(apoC-III) was found to be differentially glycosylated at Thr74
between the two groups. A major feature is the higher
abundance of linear sialyl core 1 structures [NeuAc-a-(2? 3)-
Gal-b-(1? 3)-GalNAc; sialyl-T-antigen] in lung cancer pa-
tients with a characteristic absence of the branching a-(2? 6)
sialic acid on the core GalNAc [NeuAc-a-(2? 3)-Gal-b-
(1? 3)-(NeuAc-a-(2? 6))-GalNAc; di-sialyl-T-antigen], which
was found in higher abundance in healthy volunteers. The
absence of di-sialyl moieties is attributed to epigenetic si-
lencing of a-(2? 6)-sialyltransferase gene as corroborated by
other studies. Clearly, inclusion of additional lectins, optimi-
zation of immobilization on ProteinChip arrays, and holding
capacities of lectins on SELDI-MS should be performed to
verify these findings in a larger set of clinical sample (Chen
et al., 2008).
Ratiometric detection
The first-generation lectin arrays used purified or enriched
glycoproteins samples with single-color fluorescent dye,
which led to lack of consistency and reproducibility due to
variations in labeling conditions. Also, the glycolipids were
not studied as they were lost in the sample preparation pro-
tocol and are difficult to label directly due lack of dye-reactive
functional groups (e.g., free amine groups similar to lysine
side chain of proteins). To develop semiquantitative and re-
liable analysis using internal biological reference standards
the dual-color ratiometric approach, extensively used in gene
microarrays, was successfully adapted to lectin microarrays
along with compatibility to standard image, statistical clus-
tering, and ratiometric heat map analysis (Pilobello et al.,
2007). Here, isolated micellae of mammalian cell membranes
were used, thus taking glycolipids into account, from two
different cell types with each cell type being differentially la-
beled with yellow (Cy3) dye and red (Cy5) dye (Fig. 2). As an
internal control, the dyes were swapped between the samples
to nullify variations due to derivatization or dye-related
background. Two well-characterized CHO cell lines (Pro-5,
and a mutant Lec8 that is defective in UDP–Gal transport and
resistant to agglutination by WGA) were used. The lectin
binding pattern obtained from Pro-5 and Lec8, using inde-
pendent single-color lectin array, was almost similar, which
did not reflect the true variations in the glycome structure.
Whereas a mixture of dual-color labeled (and dye-swapped)
membrane micellae of both Pro-5 and Lec8 analyzed on the
lectin array clearly highlighted the defects in glycan struc-
tures. Stark differences were seen in the binding to MAA
(preferably bound by Pro-5 which contains a-(2? 3) sialo-
sides), Galanthus nivalis agglutinin (GNA) (preferably bound
by Lec8, rich in N-linked mannose structures), Lens culinaris
lectin (LcH) (preferably bound by Lec8, rich in fucosylated
mannose core structures), and HPA and Artocarpus intergrifolia
lectin (AIA, Jacalin) (preferably bound by Lec8 with exposed
and truncated core O-linked mucin-type GalNAc residues).
The ratiometric technique was employed to differentiate the
glycome profile of naive HL-60 (human promyelocytic leuke-
mia) and its dimethyl sulfoxide induced differentiation into
neutrophils. HL-60 cells upon differentiation showed increased
levels of N-linked high Man structures, increased b-(1? 6)-
GalNAc residues, and reduced levels of a-(2? 6)-sialic acid
epitopes. The binding data with SNA was ambiguous com-
pared to Polyporus squamosus lectin (PSL) and Limulus polphe-
mus agglutinin LPA, thus highlighting the need to have larger
number of lectins to compensate for overlapping ligand se-
lectivities and to obtain unique patterns.
The versatility and sensitivity of the dual color ratiometric
approach was well illustrated by its application to the study of
virions (virus particles) derived from HIV (human immuno-
deficiency virus), SIV (simian immunodeficiency virus), and
host cell-derived microvescicles (Krishnamoorthy et al., 2009).
Microvesicles are carved out of enriched raft-like micro-
domains by exocytosis and are critical part of normal devel-
opment and homeostasis. Comparative analysis of glycome
profiling using a 68-lectin array (which included galectin-1 in
addition to plant-derived lectins) revealed that both HIV viri-
ons and host-derived microvesicles have strikingly similar
glycosylation patterns and hence the ability to evade immune
detection (Hirabayashi, 2009). Comparison of HIV and SIV
indicated subtle differences in the levels of glycoforms of gp120,
which was a major differential compared to host microvesicles.
Novel anti-HIV therapy that seeks to exploit the binding of
lectins, such as cyanovirin, to high-mannose structures of gp120
may have to tread cautiously as they may obstruct the native
microvesicular pathway as well (Li et al., 2008).
Importance of multivalent interactions
Any technological advance in glycomics using lectins could
not ignore two salient features of carbohydrate ligands,
namely, multivalency and ligand-density effects (Brewer et al.,
2002; Lee and Lee, 2000). A recent study highlights the im-
portance of ligand density (available in natural form on the
biological samples, lysates, membrane preparations, or whole
cells) on the ability of lectins or antibodies for recognition and
binding (Oyelaran et al., 2009). The antigen array used neo-
glycoconjugate containing varying amount of ligands [car-
bohydrate epitopes attached to bovine serum albumin (BSA)]
immobilized on a solid support and probed with three lectins
[Vicia villosa lectin B4 (VVL-B4), Helix pomatia agglutinin
(HPA), Soy bean agglutinin (SBL)], three monoclonal anti-
bodies and serum antibodies from patients. Study revealed
the necessity to include a given antigen or given carbohydrate
ligand in varying density both in terms of individual mole-
cules and physical arraying in order to profile subpopulations
of antibodies with variable affinities. For example, the binding
(apparent Kd) of VVL-B4 to a-GalNAc derivatized BSA
changed dramatically, by an order of magnitude, from
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>1,430 nM for 9 ligands per BSA to 129 nM for 13 ligands per
BSA. These values and relative affinities are consistent with
original studies establishing Tn-antigen (a-GalNAc-Ser) as a
specific recognition epitope for VVL-B4 (Puri et al., 1992).
Recombinant lectins
Owing to their easy isolation and commercial availability,
plant-derived lectins were a straightforward choice for the
development of lectin microarray for glycomic analysis.
However, plant-derived lectins do suffer from multiple dis-
advantages (Hsu et al., 2008). Excepting a few lectins such as
Con A, WGA, and PNA, the majority of plant-derived lectins
are inherently glycosylated. They are obtained in multiple
isoforms, called iso-lectins, in the isolation and purification
process due to genetic heterogeneity, variability in post-
translational processing by proteases, and subunit structure
(De Hoff et al., 2009). The inherent glycoprotein nature of
lectins could potentially lead to false positive binding, par-
ticularly with cell lysates and biological samples (e.g., binding
of mannose binding lectins such as DC-SIGN present in
mammalian cell lysates to high-mannose glycans present on
the immobilized plant-derived lectins). There are multiple
ways in which this problem could be addressed such as (1)
completely de-glycosylate plant-derived lectins and ensure
integrity of ligand selectivity and specificity, (2) to regenerate
all existing plant lectins using bacterial recombinant technol-
ogy, and (3) use a panel of bacterial lectins, most of which
lack glycosylation. In all the above cases carbohydrate ligand
selectivity, specificity, and affinity must be obtained on a case-
by-case basis and specific mutants using recombinant tech-
nology that abrogate ligand binding could serve as valuable
negative controls. The feasibility and utility of recombinant
bacterial lectins and their mutants for lectin microarray was
shown by Hsu and coworkers (2008) using a small set of seven
lectins. The lectins consisted of GafD (specific for b-GlcNAc),
GafD-m (a Asp88Leu mutant which does not bind b-GlcNAc),
PapGII (specific for globoside GbO4), and PapGIII (specific
for globoside GbO5) from E. coli and PA-IL (specific for Ga-
lactose), and PA-IIL (binds both fucose and mannose with
higher affinity for fucose) from Pseudomonas aeruginosa, and
RS-IIL (binds mannose and fucose with higher affinity for
mannose) from Ralstonia solanocearum. All the recombinant
lectins were expressed with GST-His6 fusion tags at the N-
terminus using pET-41 LIC/Ek vector and found not to
compromise carbohydrate–lectin interaction. The use of fu-
sion-tags in recombinant lectins could aid greatly in con-
trolled orientation of lectins during immobilization process,
which might improve sensitivity. It was found that PA-IIL
(fucose binder) bound strongly to gangliosides obtained from
porcine brain extract indicating the presence of fucosylated
gangliosides. Finally, the recombinant lectin array was used
to obtain differential patterns for micellae prepared from renal
carcinoma (ACHN and TK10) and melanoma (M14 and SK-
MEL-5) cell lines. Although all four cell lines bound to PA-IIL
(fucose/mannose binder), the binding to PA-IL (galactose
binder) and GafD (GlcNAc binder) was selective for renal cell
lines only.
Library of lectin mutants
At about the same time, Maenuma and coworkers (2008)
reported the use of a library of 35 Maackia amurensis hemag-
glutinin (MAH) mutants with various point mutations at two
amino acids, 131Gly and 133Ser, which are present in the key
CRD of the lectin. The wild-type MAH is known to bind
sialyl-T and disialyl-T antigens found on O-glycans and the
MAH mutants were found to bind carbohydrates with wider
specificities when probed with polyacrylamide conjugates
containing various glyco-epitopes. All the recombinant mu-
tants were expressed with FLAG fusion tag, which was used
to capture on polystyrene surfaces coated with anti-FLAG
antibody. This avoided the purification of bacterial lysates
and provided optimal orientation of lectins for interaction
with glycans on glycoproteins and mammalian cells. The
bound cells were labeled with crystal violet, lysed, and
quantified by colorimetry. Study of binding of various cancer
cell lines using cluster analysis revealed that groups of cells of
similar origin such as colon carcinoma, melanoma, and my-
eloid cell lines, tend to cluster together. The binding of in-
tact cells exhibited wider differential patterns compared to
polyacrylamide–glycoconjugates, which was attributed to ad-
ditional cell surface glycan and mutant lectin protein backbone
interactions. Although not in a microarray format, this study
showed the ability to generate significant number of lectin
mutants and their potential for rapid glyco-profiling of cells.
Challenges remain in terms of the quantities of biological
samples needed for flooding the lectin microarray for gly-
comic analysis. To improve the sensitivity and to utilize very
little biological samples without pooling of multiple patient
samples, Nagaraj and coworkers (2008) have shown the utility
of piezoelectric printing for lectin immobilization, using six
common lectins, on nitrocellulose slides and piezoelectric
liquid dispensing for analyte samples. This way glyco-
profiling of pure glycoproteins such as asialofetuin (ASF) and
6-sialofetuin (6-SF) could be accomplished using as little as
1 mL of 1 nm or 15 fmol of ASF at 1 mg/mL, whereas a con-
ventional lectin array would require about 450 mL for the same
analysis. In another approach for label-free detection using
electrochemical impedance spectroscopy (EIS), La Belle and
coworkers (2007) have shown that carbohydrate epitope
functionalized gold-nanoparticles and glycoproteins could be
detected on Cu/Ni/Au printed circuit boards (PCBs) using
two lectins, PNA, and SNA. The sensitivity for asialofetuin
was found to be 10 pg/mL (150 fM), which was comparable to
conventional fluorescence-based detection methods. Further
development of such tools will involve expansion and mul-
tiplexing to include a large number of lectins, miniaturization,
application of nano-particle-based application (Dai et al.,
2006), integration of antibody assisted detection (Kuno et al.,
2009), and optimization of measurement conditions (Gemei-
ner et al., 2008). An exhaustive list of lectins (including those
that are currently not employed in microarrays) along with
their source, ligand specificity, status of lectin glycosylation
and oligomerization, and metal ion requirements for optimal
activity are provided in Supplementary Table 1 along with
references (supplementary information).
Finally, a comment on lectin spot size for glycomic analysis
of intact mammalian cells deserves mention. Depending on
the size and surface area of lectin spot and density of lectin
available minor portions or side populations of mammalian
cells could be selected, leading to batch to batch inconsistency.
In other words, using simple calculations performed by us,
when an asynchronous population of 5105 cells are used in
the analyte, with a lectin array spot of 120 micron diameter,
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less than 10% of cells are captured leading to loss of 90% of
cells in the washing. The cells are perhaps lost due to lack of
availability of lectins rather than lack of specific affinity for a
given lectin. Assuming a perfectly circular morphology, a
lectin spot of 120-mm diameter will provide a surface area of
11,304 mm2. Taking Jurkat cells with a diameter of 10mm as a
model gives 78.5 mm2 for surface area of each cell. Taking a
ratio would result in a maximum of 144 Jurkat cells per lectin
spot with a diameter of 120 mm. For a total of 282 spots
(triplicate spots for 94 lectins) this would result in the capture
of 40,608 cells, which is less than 10% of total number of cells
in the analyte. Mammalian cell populations, particularly
cancer cell lines are known to exhibit side populations that
have distinct glycoform patterns and metabolic rates (Wu
and Alman, 2008; Yarema et al., 2001). Therefore, multiple
technical replicates and standardization of lectin signa-
ture pattern as a function of lectin spot diameter would
be required for analysis of whole mammalian cells. Ad-
ditionally, the washed cells (* 90%) could be subject to re-
peated analysis on the lectin array to confirm if identical
patterns are obtained.
Overview and Outlook
Advances in research over years have made it clear that
with limited number of genes in mammalian genomes, tran-
scriptome, and translated proteome, posttranslational modi-
fications in proteins are important players in regulating their
function. Glycosylation, the most abundant and complex
form of posttranslational modification, is a key regulator of
the properties of proteins and lipids that are present in
abundance on the cell surface. Glycans at the extracellular
interface mediate several interactions between or within the
cells, which in turn, control several important biological
events such as cell adhesion, cell signaling, cellular trafficking,
and protein folding, stability, and transport. Moreover, gly-
cosylation is important for regulation of many crucial cellular
processes such as development, elicitation and homeostasis
of activating and inhibitory immune responses. It is known
that several diseases such as cancer exhibit improper glyco-
sylation with striking differences from healthy tissues. Hun-
dreds of glycogenes encode enzymes such as glycosyl
transferases and sulfotransferases, which are essential for
carrying out glycan biosynthesis. An intricate network of
interactions among these enzymes and sugar–nucleotide
transporters provides the cells with a rich and complex di-
versity of glycans. Minute changes in the entire system—be it
glycogene alteration, enzyme deficit, or disease-related alter-
ation in expression, or deficiency in the availability of raw
materials (activated glycosyl donor and their metabolic pre-
cursors)—leads to modified glycan structures being presented
within the cell and on the cell surface (Schachter and Freeze,
2009). A common example of such alterations can be observed
in tumor cells that express an abnormally high degree of N-
glycan branching, extension with polylactosamine chains,
fucosylation, and sialylation, and altered degree of sulfation.
Even the O-glycans found associated with tumors are altered
with higher percentage of T antigens, sialyl-T antigens, and
Tn- and sialyl Tn-antigens with truncated glycoforms. Slight
and subtle changes in glycan structures can initiate a cascade
of undesirable cellular events. Given equal levels of expres-
sion a protein from a gene, the probability of aberrations are
much higher in the post translational glycosylation modifi-
cations, which profoundly affect the concerned biological
events. Because aberrant glycosylation are frequently ob-
served in disease conditions, they are well suited to be utilized
as biomarkers for those diseases (Hanash et al., 2008). Several
techniques including lectin-microarrays are now available
that can be used to identify these altered structures and
therefore put to diagnostic use.
Genome-wide studies were revolutionized with the advent
of whole genome DNA microarray technology about a decade
ago. Several transcription-level analyses have been success-
fully carried out for over 20,000 human genes (Young, 2000).
Gene expression profiling has since become a widespread
method for investigating biological and clinically relevant
events. However, a major problem initially was the validation
of preliminary results obtained during gene expression pro-
filing to prevent errors due to low quantities used in DNA
microarray. Most statistical methods and programs used were
lengthy and slow, and therefore diminished the total accom-
plishments of the technique. With the introduction of real-
time quantitative PCR (qPCR), which is highly sensitive and
precise, the validation of DNA microarray data has become
easy. It is now one of the most commonly used technique for
microarray data analysis. With lectin microarray as the new
upcoming glycotechnology with ultrasensitive glycan profil-
ing ability, it will be advantageous to apply qPCR array
analysis for expression profiling of glycogenes. The number of
glycan biosynthetic enzymes identified has risen significantly
and constantly since the identification of the first glycosyl
transferase as early as in the 1980s. The human genome en-
compasses a number of glycogenes, which encode the en-
zymes involved in glycan biosynthesis (Narimatsu, 2006).
Approximately 200 genes, about 1% of whole genome, are
identified to date that encode for glycosyltransferases. Use of
lectin microarray in combination with qPCR data abolishes
the need of cumbersome protocols used for individual glycan
analyses of glycoproteins and glycolipids from various sour-
ces and replaces it with a high-throughput method based on
multiple lectin–sugar interactions (Narimatsu et al., 2009). A
number of different protocols have been developed for de-
tecting alterations to the glycosylation profile of cell surfaces.
Recent advances using an ultrasensitive lectin microarray
facilitates differential glycan analysis by targeting a restricted
region of one-dot sections on a formalin-fixed tissue array
(Matsuda et al., 2008).
Another method that has developed to be a powerful tool
for structural analysis of glycans is mass spectrometry (MS). It
has proved to be a fast and high-throughput method for
glycan structure analysis. However, it does have the disad-
vantage of requiring extensive sample preparations prior to
analysis if a detailed characterization of glycan structure is
needed (Dell and Morris, 2001). Owing to immense hetero-
geneity present in glycans isolated from any natural source,
there is always a trade-off between sensitivity of character-
ization and high-throughput results. Nuclear magnetic reso-
nance (NMR) spectroscopy is a powerful technique for
detailed linkage analysis of glycans, but is limited by the
requirement of substantial quantities of homogeneous sam-
ples. On the other hand, high-performance liquid chroma-
tography (HPLC) of fluorescently labeled glycans is another
advanced technique to obtain glycan profiles on the basis of
their abundance in isolated mixtures (Domann et al., 2007).
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Development of integrated user-friendly online databases for
glycan structures analysis, lectin binding parameters, lectin
folds, and mass spectrometry reference data for fingerprinting
are critically essential (Damodaran et al., 2008; Haslam et al.,
2008; von der Lieth et al., 2006).
Each of the techniques, microarrays (lectins, synthetic and
natural carbohydrate ligands, neoglycoconjugates), qPCR,
MS analyses, glyco-informatics, NMR and HPLC provide
unique ability to identify novel alterations in glycosylation
patterns. Although each method allows for a specific advan-
tage and improvement in detection of altered glycan profile, it
is not easy to obtain detailed information of glycosylation
pattern by using any one of them in isolation. By using a
combination of several analytical methods, however, it should
be possible to determine the glycan structures and better
understand glyco-alterations that occur on cell surfaces and/
or on proteins. In summary, lectin microarrays with their
simplicity, capacity for rapid high-throughput analysis at the
‘‘point-of-care,’’ availability of lectins, and affordable low-cost
equipment requirements are well positioned for wide spread
usage in biomedical research.
Expansion of existing lectin microarrays to include mam-
malian, bacterial, and fungal lectins would add to its versa-
tility and clinical value. The existence of isolectins, multiple
glycoforms, heterogeneous preparations, and batch-to-batch
variations in plant-derived lectins are major challenges in
obtaining consistent reproducible results. The problem of
glycosylation of lectins could be overcome by recombinant
production of plant lectins in bacterial systems with con-
comitant verification of carbohydrate binding specificities
and affinities. Kulkarni and coworkers (2004; Shaaanan et al.,
1991) have expressed recombinant EcorL and showed that
absence of glycosylation on EcorL did not affect its carbohy-
drate specificity and exhibited similar quaternary structure.
However, glycosylation does seem to affect the folding pro-
cess (Mitra et al., 2003). Recombinant lectins do seem to be far
less practical compared to the ease and abundance of natural
plant lectins. It will be a demanding task to generate sufficient
repertoire of recombinant lectins with defined ligand specifi-
cities to develop a microarray and for ready-to-use clinical
applications. An ideal lectin microarray would consist of a set
of lectins with mutually exclusive or orthogonal ligand spe-
cificities, but the variety of glycoforms and their unpredictable
three-dimensional multivalent presentation on mammalian
cell surface precludes the construction of such arrays (Gabius,
2008; Gilleron et al., 1998).
Alternatively, a practical approach would be to undertake
large scale explorations of biodiversity with a focus on dis-
covery of new lectins and their biochemical characterization
and collect as many lectins as possible from lectin space or
plant kingdom. With rapid advances and growing impor-
tance of food security and plant biotechnology (Goldstein,
2002; Pusztai et al., 2008; Vasil, 2008), it should be possible to
identify novel lectins with specificities for complex glyco-
forms and their modifications such as phosphorylation, sul-
fation, acetylation, methylation, and attachment of lactic acid.
Additionally, novel modes of attachment to solid support
using the glycan residues of the lectin are anticipated to pro-
vide optimal orientation while hiding away the interfering
glycan components.
In summary, the collective information obtained using
diverse microarray technologies that employ immobilized
synthetic and natural carbohydrate ligands, neo-glycoconju-
gates, antibodies, and lectins (natural and recombinant)
would be valuable in developing glycomics-based diagnostics
and therapeutic targets (Yue and Haab, 2009). The application
of metabolic glycan engineering (MGE) using variants of
natural monosaccharide analogs as precursors and their
subsequent detection via orthogonal chemical reactions in
vivo are opening up possibilities for glycan imaging (Laughlin
and Bertozzi, 2009; Sletten and Bertozzi, 2009). Differential
glycan profiling of glycan engineered cells (expressing azide,
ketone, and thiol functionalities) using lectin microarrays
might open up new possibilities for cell and tissue engineer-
ing including stem cell differentiation (Du and Yarema;
Sampathkumar et al., 2006).
In view of the various biological processes and diseases in
which glycans play a crucial role the potential for develop-
ment of glycotherapeutics is immense. Understanding the role
of glycan structure and function in fundamental biology and
applications of high-throughput tools such as lectin micro-
array, reviewed here, will enable us to develop new-age di-
agnostics and therapeutics with higher efficacy.
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